Fertility and sexual function following orchiectomy and 2 cycles of chemotherapy for stage I high risk nonseminomatous germ cell cancer

Journal of Urology

Volumn 165, Issue 2, 2001, Pages 441-444

  Böhlen, Dominik ^a   Burkhard, Fiona C ^a   Mills, Robert ^a   Sonntag, Roland W ^a   Studer, Urs E ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Adjuvant; Chemotherapy; Fertility; Lymph node excision; Risk; Testicular neoplasms

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE; FOLLITROPIN; LUTEINIZING HORMONE; TESTOSTERONE; VINBLASTINE;

ADULT; ARTICLE; AZOOSPERMIA; CANCER ADJUVANT THERAPY; GERM CELL TUMOR; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; OLIGOSPERMIA; ORCHIECTOMY; PRIORITY JOURNAL; SEMEN ANALYSIS; SEXUAL BEHAVIOR; SEXUAL FUNCTION;

EID: 0035191189     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-200102000-00022     Document Type: Article

References (29)

1. Short course adjuvant chemotherapy in high risk stage I nonseminomatous germ-cell tumors of the testis: A medical research council report
2. Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients
3. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors
4. Sexual functioning after treatment for testicular cancer: Comparison of treatment modalities
5. Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer
6. Sexuality and fertility in long-term survivors of testicular cancer
7. L'avenir sexuel du malade guéri d'un cancer du testicul
8. The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection
9. Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parameters
10. Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: Long-term results of a prospective trial
11. Adjuvant chemotherapy in high risk stage I nonseminomatous germ cell tumors
12. Adjuvant chemotherapy for stage I nonseminomatous testicular cancer
13. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors
14. Secondary leukemia associated with a conventional dose of etoposide: Review of serial germ cell tumor protocols
15. Secondary tumors following etoposide containing therapy for germ cell cancer
16. Treatment of testicular cancer and the development of secondary malignancies
17. Semen analysis in testicular cancer and Hodgkin's disease: Pre- and post-treatment findings and implications for cryopreservation
18. Fertility after chemotherapy for testicular germ cell cancers
19. Fertility after chemotherapy for testicular cancer
20. Pre-treatment DNA ploidy of sperm cells as a predictive parameter of post-treatment spermatogenesis in patients with testicular cancer
21. Fertility after chemotherapy for testicular germ cell cancers
22. Sperm parameters and ejaculation before and after operative treatment of patients with germ-cell testicular cancer
23. Comparative study of the fertility potential of men with only one testis
24. Unilateral testicular injury from external trauma: Evaluation of semen quality and endocrine parameters
25. Fertility after chemotherapy for testicular germ cell cancer
26. Semen quality and reproductive hormones before and after orchiectomy in men with testicular cancer
27. Gonadal function after multimodality treatment in men with testicular germ cell cancer
28. Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy
29. Effect of cytotoxic therapy on sexuality and gonadal function